Nigeria’s counterfeit medicine crisis is rooted in longstanding weaknesses in the country’s pharmaceutical regulatory system, the Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), Professor Mojisola Adeyeye, has said.
The post NAFDAC DG links Nigeria’s counterfeit medicine crisis to regulatory gaps appeared first on Nairametrics.
